Clinical Trials
3 trialsNCT06084884 2026-05-22
ATHENA
AstraZeneca
Phase 1/2 Active not recruiting
NCT06096038 2026-02-20
Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC
UNC Lineberger Comprehensive Cancer Center
Phase 1/2 Recruiting
NCT01089387 2025-12-04
INSTIN
Institut National de la Santé Et de la Recherche Médicale, France
Phase 1/2 Completed